Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics · Investor's Business Daily

In This Article:

Merus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment.